Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
8.91
+0.07 (0.79%)
May 29, 2026, 12:14 PM EDT - Market open
Arvinas Market Cap
Arvinas has a market cap or net worth of $574.88 million as of May 29, 2026. Its market cap has increased by 25.22% in one year.
Market Cap
574.88M
Enterprise Value
-48.39M
1-Year Change
25.22%
Ranking
Category
Stock Price
$8.91
Market Cap Chart
Since September 27, 2018, Arvinas's market cap has increased from $516.15M to $574.88M, an increase of 11.38%. That is a compound annual growth rate of 1.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2026 | 570.37M | -25.12% |
| Dec 31, 2025 | 761.70M | -42.17% |
| Dec 31, 2024 | 1.32B | -52.94% |
| Dec 29, 2023 | 2.80B | 53.71% |
| Dec 30, 2022 | 1.82B | -58.07% |
| Dec 31, 2021 | 4.34B | 6.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prime Medicine | 596.04M |
| Valneva SE | 592.74M |
| Candel Therapeutics | 589.83M |
| Altimmune | 579.53M |
| Tectonic Therapeutic | 574.19M |
| Climb Bio | 571.31M |
| AgomAb Therapeutics NV | 571.28M |
| Ginkgo Bioworks Holdings | 568.98M |